Movement disorder emergencies in childhood
Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well...
Gespeichert in:
Veröffentlicht in: | European journal of paediatric neurology 2011-09, Vol.15 (5), p.390-404 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 404 |
---|---|
container_issue | 5 |
container_start_page | 390 |
container_title | European journal of paediatric neurology |
container_volume | 15 |
creator | Kirkham, F.J Haywood, P Kashyape, P Borbone, J Lording, A Pryde, K Cox, M Keslake, J Smith, M Cuthbertson, L Murugan, V Mackie, S Thomas, N.H Whitney, A Forrest, K.M Parker, A Forsyth, R Kipps, C.M |
description | Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n = 12), typically >10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients. |
doi_str_mv | 10.1016/j.ejpn.2011.04.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_904483521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1090379811000766</els_id><sourcerecordid>904483521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</originalsourceid><addsrcrecordid>eNqNkU1LAzEYhIMoWqt_wIP0Jgi7vtlkPwIiSPELFA_qOaTJuzbrdlOTttB_b5ZWDx5ECCSBmWF4hpATCikFWlw0KTbzLs2A0hR4CpDvkAHNWZZklMFufIOAhJWiOiCHITQAIHhW7JODjFYsL_JyQM6f3Apn2C1GxgbnDfpR_Pp37LTFMLLdSE9ta6bOmSOyV6s24PH2HpK325vX8X3y-Hz3ML5-TDTn2SKhlWCVqgsOBQrACVZaFLnmihlRClaaiaJVpXTJ8lpBXap6gnVNDROqVCI2H5KzTe7cu88lhoWc2aCxbVWHbhmkAM5j_X8oYxMRT55HZbZRau9C8FjLubcz5deSguxhykb2MGUPUwKXEWY0nW7jl5MZmh_LN70ouNwIMOJYWfQyRGqdRmM96oU0zv6df_XLrlvbWa3aD1xjaNzSdxG0pDJkEuRLP2e_JqVxybIo2BdsKJlw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>893993955</pqid></control><display><type>article</type><title>Movement disorder emergencies in childhood</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kirkham, F.J ; Haywood, P ; Kashyape, P ; Borbone, J ; Lording, A ; Pryde, K ; Cox, M ; Keslake, J ; Smith, M ; Cuthbertson, L ; Murugan, V ; Mackie, S ; Thomas, N.H ; Whitney, A ; Forrest, K.M ; Parker, A ; Forsyth, R ; Kipps, C.M</creator><creatorcontrib>Kirkham, F.J ; Haywood, P ; Kashyape, P ; Borbone, J ; Lording, A ; Pryde, K ; Cox, M ; Keslake, J ; Smith, M ; Cuthbertson, L ; Murugan, V ; Mackie, S ; Thomas, N.H ; Whitney, A ; Forrest, K.M ; Parker, A ; Forsyth, R ; Kipps, C.M</creatorcontrib><description>Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n = 12), typically >10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.</description><identifier>ISSN: 1090-3798</identifier><identifier>EISSN: 1532-2130</identifier><identifier>DOI: 10.1016/j.ejpn.2011.04.005</identifier><identifier>PMID: 21835657</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Disease ; Autoimmune Diseases of the Nervous System - mortality ; Autoimmune Diseases of the Nervous System - physiopathology ; Autoimmune Diseases of the Nervous System - therapy ; Biotin ; Brain Diseases, Metabolic, Inborn - mortality ; Brain Diseases, Metabolic, Inborn - physiopathology ; Brain Diseases, Metabolic, Inborn - therapy ; Cardiopulmonary bypass ; Child ; Chorea ; Comorbidity - trends ; Creatine ; Drugs ; Dyskinesia, Drug-Induced - mortality ; Dyskinesia, Drug-Induced - physiopathology ; Dyskinesia, Drug-Induced - therapy ; Dystonia ; Emergency Medical Services - standards ; Humans ; Infection ; Metabolic ; Movement Disorders - mortality ; Movement Disorders - physiopathology ; Movement Disorders - therapy ; Myoclonus ; Neuroleptic malignant syndrome ; Neurology ; Opsoclonus ; Organic aciduria ; Parkinsonism ; Paroxysmal Autonomic Instability with Dystonia ; Pediatrics ; Psychophysiologic Disorders - mortality ; Psychophysiologic Disorders - physiopathology ; Psychophysiologic Disorders - therapy ; Sandifer syndrome ; Status dystonicus ; Sydenham’s chorea ; Systemic lupus erythematosus ; Tremor ; Wilson’s disease</subject><ispartof>European journal of paediatric neurology, 2011-09, Vol.15 (5), p.390-404</ispartof><rights>European Paediatric Neurology Society</rights><rights>2011 European Paediatric Neurology Society</rights><rights>Copyright © 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</citedby><cites>FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejpn.2011.04.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21835657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kirkham, F.J</creatorcontrib><creatorcontrib>Haywood, P</creatorcontrib><creatorcontrib>Kashyape, P</creatorcontrib><creatorcontrib>Borbone, J</creatorcontrib><creatorcontrib>Lording, A</creatorcontrib><creatorcontrib>Pryde, K</creatorcontrib><creatorcontrib>Cox, M</creatorcontrib><creatorcontrib>Keslake, J</creatorcontrib><creatorcontrib>Smith, M</creatorcontrib><creatorcontrib>Cuthbertson, L</creatorcontrib><creatorcontrib>Murugan, V</creatorcontrib><creatorcontrib>Mackie, S</creatorcontrib><creatorcontrib>Thomas, N.H</creatorcontrib><creatorcontrib>Whitney, A</creatorcontrib><creatorcontrib>Forrest, K.M</creatorcontrib><creatorcontrib>Parker, A</creatorcontrib><creatorcontrib>Forsyth, R</creatorcontrib><creatorcontrib>Kipps, C.M</creatorcontrib><title>Movement disorder emergencies in childhood</title><title>European journal of paediatric neurology</title><addtitle>Eur J Paediatr Neurol</addtitle><description>Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n = 12), typically >10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.</description><subject>Acute Disease</subject><subject>Autoimmune Diseases of the Nervous System - mortality</subject><subject>Autoimmune Diseases of the Nervous System - physiopathology</subject><subject>Autoimmune Diseases of the Nervous System - therapy</subject><subject>Biotin</subject><subject>Brain Diseases, Metabolic, Inborn - mortality</subject><subject>Brain Diseases, Metabolic, Inborn - physiopathology</subject><subject>Brain Diseases, Metabolic, Inborn - therapy</subject><subject>Cardiopulmonary bypass</subject><subject>Child</subject><subject>Chorea</subject><subject>Comorbidity - trends</subject><subject>Creatine</subject><subject>Drugs</subject><subject>Dyskinesia, Drug-Induced - mortality</subject><subject>Dyskinesia, Drug-Induced - physiopathology</subject><subject>Dyskinesia, Drug-Induced - therapy</subject><subject>Dystonia</subject><subject>Emergency Medical Services - standards</subject><subject>Humans</subject><subject>Infection</subject><subject>Metabolic</subject><subject>Movement Disorders - mortality</subject><subject>Movement Disorders - physiopathology</subject><subject>Movement Disorders - therapy</subject><subject>Myoclonus</subject><subject>Neuroleptic malignant syndrome</subject><subject>Neurology</subject><subject>Opsoclonus</subject><subject>Organic aciduria</subject><subject>Parkinsonism</subject><subject>Paroxysmal Autonomic Instability with Dystonia</subject><subject>Pediatrics</subject><subject>Psychophysiologic Disorders - mortality</subject><subject>Psychophysiologic Disorders - physiopathology</subject><subject>Psychophysiologic Disorders - therapy</subject><subject>Sandifer syndrome</subject><subject>Status dystonicus</subject><subject>Sydenham’s chorea</subject><subject>Systemic lupus erythematosus</subject><subject>Tremor</subject><subject>Wilson’s disease</subject><issn>1090-3798</issn><issn>1532-2130</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1LAzEYhIMoWqt_wIP0Jgi7vtlkPwIiSPELFA_qOaTJuzbrdlOTttB_b5ZWDx5ECCSBmWF4hpATCikFWlw0KTbzLs2A0hR4CpDvkAHNWZZklMFufIOAhJWiOiCHITQAIHhW7JODjFYsL_JyQM6f3Apn2C1GxgbnDfpR_Pp37LTFMLLdSE9ta6bOmSOyV6s24PH2HpK325vX8X3y-Hz3ML5-TDTn2SKhlWCVqgsOBQrACVZaFLnmihlRClaaiaJVpXTJ8lpBXap6gnVNDROqVCI2H5KzTe7cu88lhoWc2aCxbVWHbhmkAM5j_X8oYxMRT55HZbZRau9C8FjLubcz5deSguxhykb2MGUPUwKXEWY0nW7jl5MZmh_LN70ouNwIMOJYWfQyRGqdRmM96oU0zv6df_XLrlvbWa3aD1xjaNzSdxG0pDJkEuRLP2e_JqVxybIo2BdsKJlw</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Kirkham, F.J</creator><creator>Haywood, P</creator><creator>Kashyape, P</creator><creator>Borbone, J</creator><creator>Lording, A</creator><creator>Pryde, K</creator><creator>Cox, M</creator><creator>Keslake, J</creator><creator>Smith, M</creator><creator>Cuthbertson, L</creator><creator>Murugan, V</creator><creator>Mackie, S</creator><creator>Thomas, N.H</creator><creator>Whitney, A</creator><creator>Forrest, K.M</creator><creator>Parker, A</creator><creator>Forsyth, R</creator><creator>Kipps, C.M</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope></search><sort><creationdate>20110901</creationdate><title>Movement disorder emergencies in childhood</title><author>Kirkham, F.J ; Haywood, P ; Kashyape, P ; Borbone, J ; Lording, A ; Pryde, K ; Cox, M ; Keslake, J ; Smith, M ; Cuthbertson, L ; Murugan, V ; Mackie, S ; Thomas, N.H ; Whitney, A ; Forrest, K.M ; Parker, A ; Forsyth, R ; Kipps, C.M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-18938af6406e90ebe8c965c4a3d97937dba188ac735fa0f7afbeff1d39a7a9213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Acute Disease</topic><topic>Autoimmune Diseases of the Nervous System - mortality</topic><topic>Autoimmune Diseases of the Nervous System - physiopathology</topic><topic>Autoimmune Diseases of the Nervous System - therapy</topic><topic>Biotin</topic><topic>Brain Diseases, Metabolic, Inborn - mortality</topic><topic>Brain Diseases, Metabolic, Inborn - physiopathology</topic><topic>Brain Diseases, Metabolic, Inborn - therapy</topic><topic>Cardiopulmonary bypass</topic><topic>Child</topic><topic>Chorea</topic><topic>Comorbidity - trends</topic><topic>Creatine</topic><topic>Drugs</topic><topic>Dyskinesia, Drug-Induced - mortality</topic><topic>Dyskinesia, Drug-Induced - physiopathology</topic><topic>Dyskinesia, Drug-Induced - therapy</topic><topic>Dystonia</topic><topic>Emergency Medical Services - standards</topic><topic>Humans</topic><topic>Infection</topic><topic>Metabolic</topic><topic>Movement Disorders - mortality</topic><topic>Movement Disorders - physiopathology</topic><topic>Movement Disorders - therapy</topic><topic>Myoclonus</topic><topic>Neuroleptic malignant syndrome</topic><topic>Neurology</topic><topic>Opsoclonus</topic><topic>Organic aciduria</topic><topic>Parkinsonism</topic><topic>Paroxysmal Autonomic Instability with Dystonia</topic><topic>Pediatrics</topic><topic>Psychophysiologic Disorders - mortality</topic><topic>Psychophysiologic Disorders - physiopathology</topic><topic>Psychophysiologic Disorders - therapy</topic><topic>Sandifer syndrome</topic><topic>Status dystonicus</topic><topic>Sydenham’s chorea</topic><topic>Systemic lupus erythematosus</topic><topic>Tremor</topic><topic>Wilson’s disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kirkham, F.J</creatorcontrib><creatorcontrib>Haywood, P</creatorcontrib><creatorcontrib>Kashyape, P</creatorcontrib><creatorcontrib>Borbone, J</creatorcontrib><creatorcontrib>Lording, A</creatorcontrib><creatorcontrib>Pryde, K</creatorcontrib><creatorcontrib>Cox, M</creatorcontrib><creatorcontrib>Keslake, J</creatorcontrib><creatorcontrib>Smith, M</creatorcontrib><creatorcontrib>Cuthbertson, L</creatorcontrib><creatorcontrib>Murugan, V</creatorcontrib><creatorcontrib>Mackie, S</creatorcontrib><creatorcontrib>Thomas, N.H</creatorcontrib><creatorcontrib>Whitney, A</creatorcontrib><creatorcontrib>Forrest, K.M</creatorcontrib><creatorcontrib>Parker, A</creatorcontrib><creatorcontrib>Forsyth, R</creatorcontrib><creatorcontrib>Kipps, C.M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><jtitle>European journal of paediatric neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kirkham, F.J</au><au>Haywood, P</au><au>Kashyape, P</au><au>Borbone, J</au><au>Lording, A</au><au>Pryde, K</au><au>Cox, M</au><au>Keslake, J</au><au>Smith, M</au><au>Cuthbertson, L</au><au>Murugan, V</au><au>Mackie, S</au><au>Thomas, N.H</au><au>Whitney, A</au><au>Forrest, K.M</au><au>Parker, A</au><au>Forsyth, R</au><au>Kipps, C.M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Movement disorder emergencies in childhood</atitle><jtitle>European journal of paediatric neurology</jtitle><addtitle>Eur J Paediatr Neurol</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>15</volume><issue>5</issue><spage>390</spage><epage>404</epage><pages>390-404</pages><issn>1090-3798</issn><eissn>1532-2130</eissn><abstract>Abstract The literature on paediatric acute-onset movement disorders is scattered. In a prospective cohort of 52 children (21 male; age range 2mo-15y), the commonest were chorea, dystonia, tremor, myoclonus, and Parkinsonism in descending order of frequency. In this series of mainly previously well children with cryptogenic acute movement disorders, three groups were recognised: (1) Psychogenic disorders ( n = 12), typically >10 years of age, more likely to be female and to have tremor and myoclonus (2) Inflammatory or autoimmune disorders ( n = 22), including N-methyl- d -aspartate receptor encephalitis, opsoclonus-myoclonus, Sydenham chorea, systemic lupus erythematosus, acute necrotizing encephalopathy (which may be autosomal dominant), and other encephalitides and (3) Non-inflammatory disorders ( n = 18), including drug-induced movement disorder, post-pump chorea, metabolic, e.g. glutaric aciduria, and vascular disease, e.g. moyamoya. Other important non-inflammatory movement disorders, typically seen in symptomatic children with underlying aetiologies such as trauma, severe cerebral palsy, epileptic encephalopathy, Down syndrome and Rett syndrome, include dystonic posturing secondary to gastro-oesophageal reflux (Sandifer syndrome) and Paroxysmal Autonomic Instability with Dystonia (PAID) or autonomic ‘storming’. Status dystonicus may present in children with known extrapyramidal disorders, such as cerebral palsy or during changes in management e.g. introduction or withdrawal of neuroleptic drugs or failure of intrathecal baclofen infusion; the main risk in terms of mortality is renal failure from rhabdomyolysis. Although the evidence base is weak, as many of the inflammatory/autoimmune conditions are treatable with steroids, immunoglobulin, plasmapheresis, or cyclophosphamide, it is important to make an early diagnosis where possible. Outcome in survivors is variable. Using illustrative case histories, this review draws attention to the practical difficulties in diagnosis and management of this important group of patients.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>21835657</pmid><doi>10.1016/j.ejpn.2011.04.005</doi><tpages>15</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1090-3798 |
ispartof | European journal of paediatric neurology, 2011-09, Vol.15 (5), p.390-404 |
issn | 1090-3798 1532-2130 |
language | eng |
recordid | cdi_proquest_miscellaneous_904483521 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Acute Disease Autoimmune Diseases of the Nervous System - mortality Autoimmune Diseases of the Nervous System - physiopathology Autoimmune Diseases of the Nervous System - therapy Biotin Brain Diseases, Metabolic, Inborn - mortality Brain Diseases, Metabolic, Inborn - physiopathology Brain Diseases, Metabolic, Inborn - therapy Cardiopulmonary bypass Child Chorea Comorbidity - trends Creatine Drugs Dyskinesia, Drug-Induced - mortality Dyskinesia, Drug-Induced - physiopathology Dyskinesia, Drug-Induced - therapy Dystonia Emergency Medical Services - standards Humans Infection Metabolic Movement Disorders - mortality Movement Disorders - physiopathology Movement Disorders - therapy Myoclonus Neuroleptic malignant syndrome Neurology Opsoclonus Organic aciduria Parkinsonism Paroxysmal Autonomic Instability with Dystonia Pediatrics Psychophysiologic Disorders - mortality Psychophysiologic Disorders - physiopathology Psychophysiologic Disorders - therapy Sandifer syndrome Status dystonicus Sydenham’s chorea Systemic lupus erythematosus Tremor Wilson’s disease |
title | Movement disorder emergencies in childhood |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A27%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Movement%20disorder%20emergencies%20in%20childhood&rft.jtitle=European%20journal%20of%20paediatric%20neurology&rft.au=Kirkham,%20F.J&rft.date=2011-09-01&rft.volume=15&rft.issue=5&rft.spage=390&rft.epage=404&rft.pages=390-404&rft.issn=1090-3798&rft.eissn=1532-2130&rft_id=info:doi/10.1016/j.ejpn.2011.04.005&rft_dat=%3Cproquest_cross%3E904483521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=893993955&rft_id=info:pmid/21835657&rft_els_id=S1090379811000766&rfr_iscdi=true |